Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Urine samples are prepared for testing  in the Swiss Laboratory for Analysis of Doping in Lausanne Switzerland.

The Associated Press

A veteran forward who played for the Tampa Bay Lightning and Dallas Stars has been banned for breaking doping rules in the latest doping case to hit Russian hockey.

The Russian Anti-Doping Agency said in a statement Wednesday that Sergei Gusev received a six-month ban from the Russian Hockey Federation for an unspecified "breach of anti-doping rules."

Gusev's ban is backdated to March 23, the same month as he played in the first round of the Kontinental Hockey League playoffs for Avtomobilist Yekaterinburg.

Story continues below advertisement

The 40-year-old Gusev started his professional career in 1992. He spent four seasons in the NHL between 1997 and 2001, first in Dallas and then in Tampa Bay, playing 89 games and scoring four goals and 10 assists.

In 2012, Gusev played on a KHL team, Avangard Omsk, which was hit by doping scandal when defenceman Anton Belov was banned for doping during the Gagarin Cup final. Belov, who served a three-month suspension, went on to play for the Edmonton Oilers.

A separate doping case in 2013 saw Ilya Solaryov, then of KHL team Barys Astana, banned by the International Ice Hockey Federation after he tested positive for banned substance salbutamol while with the Kazakhstan national team.

Doping was also alleged by Russian law enforcement to be a possible factor in the death of Avangard wing and New York Rangers first-round draft pick Alexei Cherepanov, who collapsed during a KHL game in 2008 and died the next day. The league eventually suspended five team executives and doctors for what it ruled were failures in their handling of a heart condition which apparently affected Cherepanov, rather than a case of doping.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies